Ustekinumab for Crohn's disease: a nationwide real-life observational cohort study (ICC case series)

被引:0
|
作者
Biemans, V. [1 ,2 ]
van der Meulen-de Jong, A. [3 ]
van der Woude, C. [4 ]
de Boer, N. [5 ]
Dijkstra, G. [6 ]
Oldenburg, B. [7 ]
Ponsioen, C. [8 ]
Maljaars, P. [3 ]
Haans, J. [2 ]
Pierik, M. [2 ]
Hoentjen, F. [9 ]
机构
[1] Radboudumc, Nijmegen, Netherlands
[2] MUMC, Maastricht, Netherlands
[3] LUMC, Dept Gastroenterol & Hepatol, Leiden, Netherlands
[4] Erasmus MC, Rotterdam, Netherlands
[5] Vrije Univ Amsterdam, Med Ctr, Inst Educ, Dept Gastroenterol & Hepatol, Room J393, Amsterdam, Netherlands
[6] Univ Med Ctr Groningen, Groningen, Netherlands
[7] Univ Med Ctr Utrecht, Utrecht, Netherlands
[8] AMC, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[9] Radboudumc, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
DOP036
引用
收藏
页码:S55 / S56
页数:3
相关论文
共 50 条
  • [41] Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study
    Mocci, G.
    Cuomo, A.
    Allegretta, L.
    Aragona, G.
    Colucci, R.
    Della Valle, N.
    Ferronato, A.
    Forti, G.
    Gaiani, F.
    Graziani, M. G.
    Lorenzetti, R.
    Luzza, F.
    Penna, A.
    Pica, R.
    Piergallini, S.
    Rodino, S.
    Scarcelli, A.
    Zampaletta, C.
    Cicerone, C.
    Cocco, A.
    De Angelis, G.
    Donnarumma, L.
    Pranzo, G.
    Franceschi, M.
    Gallina, S.
    Grasso, G.
    Larussa, T.
    Luppino, I.
    Faggiani, R.
    Fanigliulo, L.
    Pagnini, C.
    Perazzo, P.
    Sacco, R.
    Sebkova, L.
    Serio, M. E.
    De Monti, A.
    Picchio, M.
    Elisei, W.
    Maconi, G.
    Tursi, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S536 - S537
  • [42] Resources used in the treatment of perianal Crohn's disease and the results in a real-life cohort
    de Celix Vargas, Cristina Rubin
    Algaba, Alicia
    Guerra, Ivan
    Serrano, Angel
    Perez-Viejo, Estibaliz
    Aullo, Carolina
    Bermejo, Fernando
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2018, 41 (06): : 353 - 361
  • [43] REAL LIFE EFFECTIVENESS OF USTEKINUMAB FOR MODERATE TO SEVERE CROHN'S DISEASE
    Miranda, A.
    Cuomo, A.
    Camera, S.
    Ciacci, C.
    De Filippo, F. R.
    D'Onofrio, V.
    Melina, R.
    Manguso, F.
    Bennato, R.
    Cuomo, R.
    Mucherino, C.
    Facchiano, A.
    Rigler, G.
    Sgambato, D.
    Ciamarra, P.
    Romano, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 : S38 - S38
  • [44] Ustekinumab in Treatment of Crohn's Disease Patients with Refractory Disease: Case Series
    Truta, Brindusa
    Terdiman, Jonathan
    Mahadevan-Velayos, Uma
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S359 - S360
  • [45] Case Series: Ustekinumab Use in Metastatic Cutaneous Crohn's Disease
    Zullow, Samantha
    Lichtman, Michael K.
    Larson, Allison
    Stier, Elizabeth A.
    Farraye, Francis A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1102 - S1102
  • [46] Real-world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort
    Plevris, Nikolas
    Fulforth, James
    Siakavellas, Spyros
    Robertson, Andrew
    Hall, Rebecca
    Tyler, Amy
    Jenkinson, Philip W.
    Campbell, Iona
    Chuah, Cher Shiong
    Kane, Claire
    Veryan, Jennifer
    Lam, Wai Liam
    Saunders, Jayne
    Kelly, Christopher
    Gaya, Daniel
    Jafferbhoy, Hasnain
    Macdonald, Jonathan C.
    Seenan, John Paul
    Mowat, Craig
    Naismith, Graham
    Potts, Lindsay F.
    Sutherland, Diarmid Ian
    Watts, David
    Arnott, Ian
    Bain, Gillian
    Jones, Gareth
    Lees, Charlie W.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (08) : 2067 - 2075
  • [47] Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort
    af Bjorkesten, Clas-Goran
    Ilus, Tuire
    Hallinen, Taru
    Soini, Erkki
    Eberl, Anja
    Hakala, Kalle
    Heikura, Mikko
    Jussila, Airi
    Koskela, Ritva
    Koskinen, Inka
    Moilanen, Veikko
    Nielsen, Christian
    Nieminen, Urpo
    Nuutinen, Heikki
    Heikkinen, Markku
    Suhonen, Ulla-Maija
    Tillonen, Jyrki
    Utriainen, Karri
    Vihriala, Ilkka
    Wennerstrom, Christina
    Borsi, Andras
    Nissinen, Riikka
    Koivunen, Minni R.
    Sipponen, Taina
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (12) : 1507 - 1513
  • [48] Real-life dosing patterns and concomitant drug use among ustekinumab-treated patients with Crohn's disease
    af Bjorkesten, C. G.
    Ilus, T.
    Hallinen, T.
    Soini, E.
    Eberl, A.
    Hakala, K.
    Heikura, M.
    Hirsi, E.
    Jussila, A.
    Kellokumpu, M.
    Koskela, R.
    Koskinen, I.
    Moilanen, V.
    Nielsen, C.
    Nieminen, U.
    Nuutinen, H.
    Heikkinen, M.
    Suhonen, U. M.
    Tillonen, J.
    Utriainen, K.
    Vihriala, I.
    Wennerstrom, C.
    Borsi, A.
    Nissinen, R.
    Koivunen, M.
    Sipponen, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S066 - S066
  • [49] Vedolizumab: Real-life outcomes to therapy in Crohn's disease
    Pulusu, S. S. R.
    Krishnaprasad, K.
    Cheng, D.
    Mogilevski, T.
    Flanagan, E.
    Parthasarathy, N.
    Wu, C.
    Prosser, R.
    Sawyer, E.
    Rizvi, Q. U. A.
    Taylor, K.
    Cooke, S.
    Mahy, G.
    Sparrow, M.
    Andrews, J.
    Connor, S.
    Bampton, P.
    Ghaly, S.
    Van Langenberg, D.
    Bell, S.
    De Cruz, P.
    Begun, J.
    Lawrance, I.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 143 - 143
  • [50] Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study
    Holvoet, Tom
    Truyens, Marie
    De Galan, Cara
    Peeters, Harald
    Gismero, Francisco Mesonero
    Elorza, Ainara
    Torres, Paola
    Vandermeulen, Liv
    Jauregui-Amezaga, Aranzazu
    Ferreiro-Iglesias, Rocio
    Zabana, Yamile
    Reverter, Laia Peries
    Geldof, Jeroen
    Lobaton, Triana
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)